Prognostic value of cardiac magnetic resonance early after ST-segment elevation myocardial infarction in older patients.
Fecha de publicación:
Autores de INCLIVA
Participantes ajenos a INCLIVA
- Gabaldón-Pérez A
- Gavara J
- López-Lereu MP
- Monmeneu JV
- Moratal D
- Valente F
- Lorenzatti D
- Ortiz-Pérez JT
- Rodríguez-Palomares JF
Grupos y Plataformas de I+D+i
Abstract
BACKGROUND: older patients with ST-segment elevation myocardial infarction (STEMI) represent a very high-risk population. Data on the prognostic value of cardiac magnetic resonance (CMR) in this scenario are scarce. METHODS: the registry comprised 247 STEMI patients over 70 years of age treated with percutaneous intervention and included in a multicenter registry. Baseline characteristics, echocardiographic parameters and CMR-derived left ventricular ejection fraction (LVEF, %), infarct size (% of left ventricular mass) and microvascular obstruction (MVO, number of segments) were prospectively collected. The additional prognostic power of CMR was assessed using adjusted C-statistic, net reclassification index (NRI) and integrated discrimination improvement index (IDI). RESULTS: during a 4.8-year mean follow-up, the number of first major adverse cardiac events (MACE) was 66 (26.7%): 27 all-cause deaths and 39 re-admissions for acute heart failure. Predictors of MACE were GRACE score (HR 1.03 [1.02-1.04], P < 0.001), CMR-LVEF (HR 0.97 [0.95-0.99] per percent increase, P = 0.006) and MVO (HR 1.24 [1.09-1.4] per segment, P = 0.001). Adding CMR data significantly improved MACE prediction compared to the model with baseline and echocardiographic characteristics (C-statistic 0.759 [0.694-0.824] vs. 0.685 [0.613-0.756], NRI = 0.6, IDI = 0.08, P < 0.001). The best cut-offs for independent variables were GRACE score > 155, LVEF < 40% and MVO = 2 segments. A simple score (0, 1, 2, 3) based on the number of altered factors accurately predicted the MACE per 100 person-years: 0.78, 5.53, 11.51 and 78.79, respectively (P < 0.001). CONCLUSIONS: CMR data contribute valuable prognostic information in older patients submitted to undergo CMR soon after STEMI. The Older-STEMI-CMR score should be externally validated.
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Datos de la publicación
- ISSN/ISSNe:
- 0002-0729, 1468-2834
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 36436010
AGE AND AGEING OXFORD UNIV PRESS
Citas Recibidas en Web of Science: 4
Documentos
- No hay documentos
Filiaciones
Keywords
- cardiac magnetic resonance; myocardial infarction; older patients; older people; prognosis; risk
Financiación
Proyectos y Estudios Clínicos
Un estudio multidisciplinar para avanzar en el entendimiento de los mecanismos básicos y la exploración de nuevas oportunidades terapéuticas en el infarto agudo de miocardio. Foco en los factores VEGF-A165b y ST2.
Investigador Principal: CÉSAR RIOS NAVARRO
FI18/00320 . INSTITUTO SALUD CARLOS III . 2019
Resolution of microvascular obstruction after myocardial infarction. A multidisciplinary approach to assess the structural and clinical consequences and to evaluate new therapeutic options.
Investigador Principal: VICENT BODÍ PERIS
PI20/00637 . INSTITUTO SALUD CARLOS III . 2021
AYUDAS JUAN DE LA CIERVA INCORPORACIÓN 2020
Investigador Principal: ANA MARÍA ORTEGA GUTIÉRREZ
IJC2020-045308-I . MINISTERIO DE CIENCIA E INNOVACIÓN . 2022
A multidisciplinary study to advance in the understanding of the basic mechanisms and clinical implications of microvascular obstruction after acute myocardial infarction. Exploration of novel diagnostic and therapeutic opportunities.
Investigador Principal: VICENT BODÍ PERIS
PROMETEO/2021/008 . CONSELLERIA EDUCACION/INNOVACION,UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL/EMPLEO . 2021
Cita
Prognostic value of cardiac magnetic resonance early after ST-segment elevation myocardial infarction in older patients. Gabaldón A, Marcos V, Gavara J, López MP, Monmeneu JV, Pérez N, Ríos C et al. AGE AND AGEING. 2022 noviembre 02. 51 (11):DOI:10.1093/ageing/afac248. PMID:36436010.
Portal de investigación